NASDAQ:ACHV

Achieve Life Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy ACHV

*Your capital is at risk

$4.92

-0.110 (-2.19%)

At Close: Jun 03, 2026

Achieve Life Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 82.80. In total, the insiders bought 31.94M and sold 763.94K ACHV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	82.80
● Buy	31.94M shares
● Sell	763.94K shares
88% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Apr 17, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 82.8. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (88% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 04, 2025 Buy	Performance Restricted Stock Unit (PRSU) M-Exempt	Wan Jerry Principal Accounting Officer	Officer	9 600 Value: $26.8K
Sep 04, 2025 Buy	Common Stock M-Exempt	Wan Jerry Principal Accounting Officer	Officer	34 100 Value: $95.1K
Sep 04, 2025 Buy	Performance Restricted Stock Unit A-Award	Stewart Richard Alistair Chieve Executive Officer	Officer	157 500 Value: $439.4K
Sep 04, 2025 Buy	Performance Restricted Stock Unit A-Award	Oki Mark K Chief Financial Officer	C-Suite Officer	168 000 Value: $468.7K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Slaoui Kristen B. Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Phelan Nancy R. Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Sellig Thomas Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Martell Bridget A Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	King Thomas Braxton Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Duty Stuart Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Duty Stuart Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	King Thomas Braxton Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Martell Bridget A Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Sellig Thomas Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Phelan Nancy R. Director	Director	31 500 Value: $120.6K
Jun 06, 2025 Buy	Stock Option (right to buy) A-Award	Slaoui Kristen B. Director	Director	31 500 Value: $120.6K
Mar 17, 2025 Buy	Common Stock P-Purchase	Oki Mark K Chief Financial Officer	C-Suite Officer	10 000 Value: $28.9K
Mar 17, 2025 Buy	Common Stock P-Purchase	Stewart Richard Alistair Chieve Executive Officer	Officer	10 000 Value: $28.6K
Mar 17, 2025 Buy	Common Stock P-Purchase	Stewart Richard Alistair Chieve Executive Officer	Officer	10 000 Value: $28.6K
Mar 17, 2025 Buy	Common Stock P-Purchase	Oki Mark K Chief Financial Officer	C-Suite Officer	10 000 Value: $28.9K
Jan 28, 2025 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Wan Jerry Principal Accounting Officer	Officer	48 000 Value: $149.3K
Jan 28, 2025 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Xinos Jaime Chief Commercial Officer	Officer	100 000 Value: $311.0K
Jan 28, 2025 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Jacobs Cindy President & Cmo	CEO / President	130 000 Value: $404.3K
Jan 28, 2025 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Jacobs Cindy President & Cmo	CEO / President	130 000 Value: $404.3K
Jan 28, 2025 Buy	Performance Restricted Stock Unit (PRSU) A-Award	Xinos Jaime Chief Commercial Officer	Officer	100 000 Value: $311.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ACHIEVE LIFE SCIENCES, INC.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol....

Read Full Profile Here